Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
€59.31
购买此电子书可免费获赠一本！
格式 EPUB ● 网页 268 ● ISBN 9781315355900 ● 编辑 Kerry B. (Pfizer, Cambridge, Massachusetts, USA) Barker & Sr., Ralph B. (Boston University, Massachusetts, USA) D’Agostino ● 出版者 CRC Press ● 发布时间 2016 ● 下载 3 时 ● 货币 EUR ● ID 5021283 ● 复制保护 Adobe DRM
需要具备DRM功能的电子书阅读器
来自同一作者的更多电子书 / 编辑
128,650 此类电子书
